HUBS vs VNDA · P/E 96, rev $1.79B vs rev $102.2M
HubSpot Inc (HUBS) versus Vanda Pharmaceuticals Inc (VNDA) — a side-by-side from cached financials, not a winner call.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
Vanda Pharmaceuticals Inc (VNDA) is a biotechnology company listed on NASDAQ.
Latest reported HUBS revenue for 2026-06-30 was $1.79B. Net income was $75.9M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
Latest reported VNDA revenue for 2026-06-30 was $102.2M. Net income was -$111.1M. Revenue was up 97.7% from 2026-03-31 to 2026-06-30. VNDA currently screens at market cap $358.4M.
HUBS currently screens at market cap $9.36B and trailing P/E 96.2. VNDA currently screens at market cap $358.4M.
Not investment advice. Open the HUBS and VNDA stock pages for the full models.
Not investment advice.